Bio-Techne TECH Diagnostics And Spatial Biology — Restructuring Costs Net Of Adjustments
Discontinued — last reported Q2 '25
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept tech:RestructuringCostsNetOfAdjustments.
The official record: Bio-Techne’s 10-Q, filed February 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's diagnostics and spatial biology — restructuring costs net of adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's diagnostics and spatial biology — restructuring costs net of adjustments?
- Bio-Techne (TECH) reported diagnostics and spatial biology — restructuring costs net of adjustments of -$19K in Q4 2024.
- How has Bio-Techne's diagnostics and spatial biology — restructuring costs net of adjustments changed year-over-year?
- Bio-Techne's diagnostics and spatial biology — restructuring costs net of adjustments decreased by 102.6% year-over-year, from $739K to -$19K.
- What does diagnostics and spatial biology — restructuring costs net of adjustments mean?
- The net expenses incurred from reorganizing operations within the diagnostics and spatial biology business unit.
- How do you interpret diagnostics and spatial biology — restructuring costs net of adjustments?
- An increase indicates significant organizational change or cost-cutting efforts, which may temporarily depress segment margins but could improve long-term profitability. A decrease suggests the completion of restructuring phases or a period of operational stability.
- How does diagnostics and spatial biology — restructuring costs net of adjustments compare across companies?
- Peers in the life sciences and diagnostics sector often report similar charges as 'special items' or 'restructuring expenses' during periods of integration following acquisitions or strategic pivots.